Resolution of Sickle Cell Leg Ulcers With Voxelotor
Status:
Recruiting
Trial end date:
2024-01-19
Target enrollment:
Participant gender:
Summary
This study is a Phase 3, multicenter, randomized, placebo-controlled study to evaluate the
efficacy of voxelotor and standard of care for the treatment of leg ulcers in participants
with sickle cell disease. The study is divided into a 5 study periods: Screening, Run-in,
Randomized Treatment, Open-label Treatment, and Follow-up/End of Study (EOS).
The study will be conducted in approximately 80 eligible participants at approximately 20
global clinical trial sites.